Short answer · Medically reviewed summary · Last updated: 2026-05-08
Trisomy 13 Syndrome, also known as Patau Syndrome, is a chromosomal disorder with no curative treatment; therefore, management focuses on supportive care and addressing specific medical complications. Treatment is highly personalized, prioritizing the patient's quality of life through a multidisciplinary approach that manages cardiac, respiratory, and neurological challenges. What are the primary treatment approaches for Trisomy 13 Syndrome? Because Trisomy 13 Syndrome impacts almost every organ system, medical care is strictly supportive.
Trisomy 13 Syndrome, also known as Patau Syndrome, is a chromosomal disorder with no curative treatment; therefore, management focuses on supportive care and addressing specific medical complications. Treatment is highly personalized, prioritizing the patient's quality of life through a multidisciplinary approach that manages cardiac, respiratory, and neurological challenges.
Because Trisomy 13 Syndrome impacts almost every organ system, medical care is strictly supportive. First-line treatments aim to stabilize the infant’s immediate health needs. This often involves neonatal intensive care for respiratory support, such as supplemental oxygen or mechanical ventilation, and nutritional support, which may include gastrostomy (G-tube) feeding if the infant has difficulty swallowing. Decisions regarding aggressive interventions are made through shared decision-making between parents and the medical team based on the child's specific prognosis.
Managing Patau Syndrome requires a coordinated, multidisciplinary care team. Effective management typically involves the following specialists:
While there are currently no disease-modifying therapies for Patau Syndrome, research continues into understanding the developmental pathways disrupted by the extra chromosome. Clinical focus remains on improving supportive care techniques to enhance comfort and longevity. Currently, 31 members of the DiseaseMaps.org community are sharing their lived experiences, which helps researchers better understand the long-term management needs of individuals living with Trisomy 13 Syndrome.
Medical disclaimer: This information is for educational purposes only and does not replace professional medical advice; always consult your personal care team regarding specific treatment decisions.